Summary of COVID-19 metronidazole studies

1. Kazempour et al., Anti-inflammatory Effect of Metronidazole in Hospitalized Patients with Pneumonia due to COVID-19

44 patient metronidazole late treatment RCT: 20% higher ICU admission (p=1), 25% shorter hospitalization (p=0.9), and 43% higher need for oxygen therapy (p=0.8).
RCT 44 hospitalized patients with COVID-19 pneumonia showing no significant differences for oxygen saturation, length of hospital stay, or mortality with metronidazole treatment. The metronidazole group had significantly lower ESR levels on day 7.
Sep 2021, Iranian J. Pharmaceutical Research, https://doi.org/10.22037/ijpr.2021.114567.14917, https://c19p.org/kazempour